Company’s 36-month beta value is 3.56.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CDIO is 48.21M, and currently, short sellers hold a 2.59% ratio of that floaft. The average trading volume of CDIO on March 27, 2025 was 2.39M shares.
CDIO) stock’s latest price update
The stock price of Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) has dropped by -3.95 compared to previous close of 0.43. Despite this, the company has seen a fall of -6.66% in its stock price over the last five trading days. businesswire.com reported 2025-03-26 that CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC’s 74th Annual Scientific Session & Expo.
CDIO’s Market Performance
Cardio Diagnostics Holdings Inc (CDIO) has experienced a -6.66% fall in stock performance for the past week, with a -16.90% drop in the past month, and a -60.13% drop in the past quarter. The volatility ratio for the week is 9.33%, and the volatility levels for the past 30 days are at 12.05% for CDIO. The simple moving average for the past 20 days is -5.18% for CDIO’s stock, with a -12.81% simple moving average for the past 200 days.
CDIO Trading at -15.19% from the 50-Day Moving Average
After a stumble in the market that brought CDIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.80% of loss for the given period.
Volatility was left at 12.05%, however, over the last 30 days, the volatility rate increased by 9.33%, as shares sank -7.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.01% lower at present.
During the last 5 trading sessions, CDIO fell by -5.34%, which changed the moving average for the period of 200-days by -38.51% in comparison to the 20-day moving average, which settled at $0.4334. In addition, Cardio Diagnostics Holdings Inc saw -55.21% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDIO starting from Philibert Robert, who purchase 34,075 shares at the price of $0.29 back on Sep 06 ’24. After this action, Philibert Robert now owns 1,683,867 shares of Cardio Diagnostics Holdings Inc, valued at $9,763 using the latest closing price.
Dogan Meeshanthini, the Chief Technology Officer of Cardio Diagnostics Holdings Inc, purchase 68,965 shares at $0.29 during a trade that took place back on Sep 06 ’24, which means that Dogan Meeshanthini is holding 197,310 shares at $20,000 based on the most recent closing price.
Stock Fundamentals for CDIO
Current profitability levels for the company are sitting at:
- -239.78 for the present operating margin
- -0.41 for the gross margin
The net margin for Cardio Diagnostics Holdings Inc stands at -240.28. The total capital return value is set at -0.84. Equity return is now at value -133.96, with -111.20 for asset returns.
Based on Cardio Diagnostics Holdings Inc (CDIO), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -7.56. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -448.81.
Currently, EBITDA for the company is -8.09 million with net debt to EBITDA at 0.88. When we switch over and look at the enterprise to sales, we see a ratio of 408.48. The receivables turnover for the company is 1.87for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.92.
Conclusion
In a nutshell, Cardio Diagnostics Holdings Inc (CDIO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
